 |
|
|
| |
Features of the Metabolic Syndrome Are Associated With Lack
of Serum ALT Normalization During Therapy for Chronic Hepatitis B
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Scott Fung,1 Hiroshi Yatsuhashi,2 Won Young Tak,3 Mustafa K. Celen,4 John F. Flaherty,5 Kyungpil Kim,5 Robert P. Myers,5 G. Mani Subramanian,5 Stephen D. Ryder,6 Manoj Sharma,7 Mindie H. Nguyen,8 Harry L.A. Janssen9
1University of Toronto, Ontario, Canada; 2National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan; 3Kyungpook National University Hospital, Daegu, Korea; 4Dicle Üniversitesi, Diyarbakir, Turkey; 5Gilead Sciences, Inc., Foster City, CA;
6Nottingham University Hospitals NHS Trust, Nottingham, UK; 7Institute of Liver and Biliary Sciences, New Delhi, India; 8Stanford University Medical Center, Stanford, CA; 9Toronto Center for Liver Diseases, University Health Network, Toronto, Ontario, Canada
References
1. Babusis D, et al. Mol Pharm 2013;10:459-66; 2. Lee WA, et al. Antimicrob Agents Chemother 2005;49:1898-906; 3. Murakami E, et al. Antimicrob Agents Chemother 2015;59:3563-9; 4. Agarwal K, et al. J Hepatol 2015;62:533-40; 5. Sax P, et al. Lancet 2015;385:2606-15; 6. Zhao SS, et al. Virol J 2011;8:111; 7. Jacobson I, et al. EASL 2014, poster 1084; 8. Terrault NA, et al. Hepatology 2016;63:261-83.
|
| |
|
|
|
|
|
